Antiangiogenic Therapy
Journal:
Current Pharmaceutical Design
Volume:
10
Page:
27-37
Author(s):
Daniel Albo, Thomas N. Wang and George P. Tuszynski
The Urokinase Plasminogen Activator System: Role in Malignancy
Journal:
Current Pharmaceutical Design
Volume:
10
Page:
39-49
Author(s):
Michael J. Duffy
Resistance to Anti-VEGF Agents
Journal:
Current Pharmaceutical Design
Volume:
10
Page:
51-64
Author(s):
Ton N. C. and Jayson G. C.
Molecular Targeting of Lymphatics for Therapy
Journal:
Current Pharmaceutical Design
Volume:
10
Page:
65-74
Author(s):
S. A. Stacker, R. A. Hughes and M. G. Achen
Development and Engineering of Lymphatic Endothelial Cells: Clinical Implications
Journal:
Current Pharmaceutical Design
Volume:
10
Page:
75-80
Author(s):
Jorg Wilting and Lothar Schweigerer
Subject Index to Volume 9
Journal:
Current Pharmaceutical Design
Volume:
10
Page:
89-108
Author(s):
Bentham Science Publishers
Sialic Acid Donors: Chemical Synthesis and Glycosylation
Journal:
Current Organic Synthesis
Volume:
1
Page:
31-46
Author(s):
Dino K. Ress and Robert J. Linhardt
Antitumor Titanium Compounds
Journal:
Mini-Reviews in Medicinal Chemistry
Volume:
4
Page:
49-60
Author(s):
F. Caruso and M. Rossi
Recent Studies on Natural Products as Anticancer Agents
Journal:
Current Topics in Medicinal Chemistry
Volume:
4
Page:
241-265
Author(s):
Angel G. Ravelo, Ana Estevez-Braun, Haydee Chavez-Orellana, Elisa Perez-Sacau and Dulce Mesa-Siverio
The TOLL-like / Type-I Interferon Pathways as Emerging Therapeutic Targets for Autoimmune Diseases
Journal:
Drug Design Reviews - Online (Discontinued)
Volume:
1
Page:
53-74
Author(s):
Patrick Englebienne